Advanced search
Publication Cover
Acta Cardiologica Volume 77, 2022 - Issue 9
Submit an article Journal homepage
162
Views
4
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Anthracycline-induced cardiotoxicity in women without cardiovascular diseases: molecular and genetic predictors

Kristina V. Kopevaa Department of Myocardial Pathology (Tomsk, Russian Federation), Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, RussiaCorrespondence[email protected]
,
Elena V. Grakovaa Department of Myocardial Pathology (Tomsk, Russian Federation), Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia
,
Sergey N. Shilovb Department of Pathological Physiology and Clinical Pathophysiology (Novosibirsk, Russian Federation), Novosibirsk State Medical University, Novosibirsk, Russia
,
Ekaterina N. Berezikovab Department of Pathological Physiology and Clinical Pathophysiology (Novosibirsk, Russian Federation), Novosibirsk State Medical University, Novosibirsk, Russia
,
Anna A. Popovab Department of Pathological Physiology and Clinical Pathophysiology (Novosibirsk, Russian Federation), Novosibirsk State Medical University, Novosibirsk, Russia
,
Maria N. Neupokoevab Department of Pathological Physiology and Clinical Pathophysiology (Novosibirsk, Russian Federation), Novosibirsk State Medical University, Novosibirsk, Russia
,
Elena T. Ratushnyakb Department of Pathological Physiology and Clinical Pathophysiology (Novosibirsk, Russian Federation), Novosibirsk State Medical University, Novosibirsk, Russia
&
Alexander T. Teplyakova Department of Myocardial Pathology (Tomsk, Russian Federation), Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia
 show all
Pages 805-814 | Received 15 Jun 2021, Accepted 24 Sep 2021, Published online: 16 Nov 2021

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Patrizio Lancellotti, Hélène Petitjean, Nils de Marneffe & Bernard Cosyns. (2022) Focus issue on cardiomyopathies. Acta Cardiologica 77:9, pages 765-767.
Read now

Articles from other publishers (3)

Kristina V. Kopeva, Elena V. Grakova, Sergey N. Shilov, Ekaterina N. Berezikova, Elena T. Bobyleva & Alexander T. Teplyakov. (2023) Tetranectin as a potential novel prognostic biomarker in anthracycline-related cardiac dysfunction. Heart and Vessels 38:10, pages 1256-1266.
Crossref
Alexia Alexandraki, Elisavet Papageorgiou, Marina Zacharia, Kalliopi Keramida, Andri Papakonstantinou, Carlo M. Cipolla, Dorothea Tsekoura, Katerina Naka, Ketti Mazzocco, Davide Mauri, Manolis Tsiknakis, Georgios C. Manikis, Kostas Marias, Yiola Marcou, Eleni Kakouri, Ifigenia Konstantinou, Maria Daniel, Myria Galazi, Effrosyni Kampouroglou, Domen Ribnikar, Cameron Brown, Georgia Karanasiou, Athos Antoniades, Dimitrios Fotiadis, Gerasimos Filippatos & Anastasia Constantinidou. (2023) New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review. Cancers 15:13, pages 3290.
Crossref
Mo-Yun Li, Li-Ming Peng & Xiao-Ping Chen. (2022) Pharmacogenomics in drug-induced cardiotoxicity: Current status and the future. Frontiers in Cardiovascular Medicine 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.